UK pharma to consider ban on doctor gifts
February 5, 2009Medical Communications ABPI, Code of Practice, ethics
All gifts from pharma companies to doctors and to medical students – should be banned, according to a new report …
Mixed reaction for national dementia strategy
February 4, 2009NHS, hc
The government's national dementia strategy, announced this week, has received a mixed reception from patient groups and the media. The …
NICE approves Sutent but rejects rivals
February 4, 2009Sales and Marketing NICE, par
NICE has approved Pfizer's Sutent but rejected three other treatments for kidney cancer. The decision is one of the first …
How ‘in line’ communications won it for Obama
February 3, 2009Medical Communications digi
It is undeniable that we live in an 'online' era: digital media and technology have infiltrated almost every aspect of …
The Brand MOT
February 3, 2009Sales and Marketing branding, marketing
To have a car on the road once it's more than three years old requires an MOT – an annual …
The Pharmafocus Interview: David Gillen
February 3, 2009Research and Development Pfizer, UK, medicines access
David Gillen says he is a born optimist. But Pfizer UK’s medical director says this positive outlook doesn’t blind him …
PM Society ad awards – results
February 3, 2009Medical Communications PM Soc, awards
The Pharmaceutical Marketing Society annual advertising awards on Friday were enjoyed in their traditional glittering style, and celebrated the industry's …
Chinese contract manufacturers to benefit from downturn
February 2, 2009Manufacturing and Production CMO, China
China's contract manufacturing organisation market was valued at more than $70 billion in 2007, with pharmaceuticals comfortably the largest contributor, …
Evidence HRT could reduce bowel cancer risk
February 2, 2009Research and Development, Sales and Marketing HRT
A new study has found more evidence that hormone replacement therapy (HRT) may reduce a woman's risk of bowel cancer. …
The Pfizer-Wyeth merger
February 2, 2009Research and Development, Sales and Marketing Pfizer, Wyeth, merger, sales
Before the merger, Pfizer faced a significant contraction in sales. Datamonitor's analysis suggests that the company's sales were declining at …
AstraZeneca to cut more jobs as sales stagnate
January 30, 2009Sales and Marketing AZ, restructure
AstraZeneca's revenues will see virtually no growth in 2009, and the company has extended its cost cutting programme. Chief executive …
Pharma additives ‘risk to premature infants’
January 30, 2009Manufacturing and Production additives, excipients
Difficulties in dosing medicines for premature babies mean some may be exposed to high levels of pharmaceutical excipients which, despite …
Crucell linked with new takeover suitors
January 29, 2009Sales and Marketing Crucell, MA
Dutch vaccines firm Crucell could be snapped up by other pharmaceutical companies after Wyeth pulled out of negotiations to buy …
Independent study into NICE’s methods
January 29, 2009Sales and Marketing NICE, hc
NICE has asked an eminent academic and NHS reformer to conduct an independent study of its approach to appraising new …
RoActemra approved in Europe
January 29, 2009Sales and Marketing RoActemra, Roche
The European Commission has approved Roche's RoActemra as a treatment for rheumatoid arthritis. Schering-Plough's Remicade, Wyeth's Enbrel and Abbott's Humira …
Plavix sales help BMS into profit
January 29, 2009Sales and Marketing BMS, Plavix
Strong fourth quarter sales of its blockbuster blood thinner Plavix have helped Bristol-Myers Squibb back into the black. Net earnings …
Novartis launches Extavia in Europe
January 28, 2009Sales and Marketing Extavia, MS
Novartis has launched its new multiple sclerosis injection Extavia in Europe and hopes this will lay the groundwork for an …
Who owns the brand?
January 27, 2009Sales and Marketing branding, marketing
For all of us in brand marketing, it is worth remembering that creating and nurturing a brand can be like …
Roche and Novo Nordisk to restrict distribution
January 27, 2009Manufacturing and Production supply chain
Roche and Novo Nordisk are the latest companies to cut the number of wholesalers allowed to supply their medicines to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
